Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury

por Akhtar, Saghir, Yousif, Mariam H. M., Chandrasekhar, Bindu, Benter, Ibrahim F.
Publicado 2012

Chronic Treatment with Ang-(1-7) Reverses Abnormal Reactivity in the Corpus Cavernosum and Normalizes Diabetes-Induced Changes in the Protein Levels of ACE, ACE2, ROCK1, ROCK2 and...

por Yousif, Mariam H. M., Makki, Batoul, El-Hashim, Ahmed Z., Akhtar, Saghir, Benter, Ibrahim F.
Publicado 2014

Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor

por Akhtar, Saghir, Chandrasekhar, Bindu, Attur, Sreeja, Dhaunsi, Gursev S., Yousif, Mariam H. M., Benter, Ibrahim F.
Publicado 2015

Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction

por Akhtar, Saghir, Yousif, Mariam H. M., Dhaunsi, Gursev S., Sarkhouh, Fatma, Chandrasekhar, Bindu, Attur, Sreeja, Benter, Ibrahim F.
Publicado 2013

Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo

por Akhtar, Saghir, Al-Zaid, Bashayer, El-Hashim, Ahmed Z., Chandrasekhar, Bindu, Attur, Sreeja, Yousif, Mariam H. M., Benter, Ibrahim F.
Publicado 2015